Niva Bupa Health Insurance Company Ltd Share Price – NSE  / BSE

Insurance, Small Cap

The company's board has also approved Bhatia's appointment as an Additional Director in the capacity of Non-Executive Independent Director for a term of five consecutive years, subject to shareholders' approval.

Meanwhile, Milind Gajanan Barve has resigned as Non-Executive Independent Director and Chairman of the Board, effective from the close of business hours on June 2, 2026, citing persistent health issues. Barve stated that there were no material reasons for his resignation other than those disclosed in his resignation letter.

Niva Bupa Health Insurance Company is a leading standalone health insurers in India. As of 31 March 2025, Niva Bupa has over 212 physical branches across India. It additionally offers health insurance through its ecosystem partners including 1.8+ lakh agents, 540 brokers, and over 100 banca & other corporate agency partners.

The company's standalone net profit rose 31.21% to Rs 206.08 crore while total income rose 18.51% to Rs 1,626.21 crore in Q4 FY25 over Q4 FY24.

Shares of Niva Bupa Health Insurance shed 0.73% to Rs 83.36 on the BSE.

Powered by Capital Market - Live News

Niva Bupa Health Insurance Company has appointed Ashwani Bhatia (DIN: 07423221) as an Additional Director in the category of Non-Executive, Independent Director, for a term of five (5) consecutive years with effect from 03 June 2026, subject to approval of the shareholders.

Simultaneously, the Board has also approved the appointment of Ashwani Bhatia as Chairperson of the Board effective 03 June 2026.

Niva Bupa Health Insurance Company announced the resignation of Milind Gajanan Barve (DIN: 00087839), Non-Executive, Independent Director with effect from 02 June 2026.

Net profit of Niva Bupa Health Insurance Company rose 67.47% to Rs 345.13 crore in the quarter ended March 2026 as against Rs 206.08 crore during the previous quarter ended March 2025. Sales rose 29.10% to Rs 1971.95 crore in the quarter ended March 2026 as against Rs 1527.42 crore during the previous quarter ended March 2025.

For the full year,net profit declined 38.75% to Rs 130.78 crore in the year ended March 2026 as against Rs 213.52 crore during the previous year ended March 2025. Sales rose 23.97% to Rs 6067.57 crore in the year ended March 2026 as against Rs 4894.46 crore during the previous year ended March 2025.

Powered by Capital Market - Live News